Prospects for personalized Helicobacter pylori eradication therapy. Pro et contra

被引：0
|
作者：
Simanenkov, Vladimir I. [1 ]
Alekseenko, Sergei A. [2 ]
机构：
[1] Mechnikov North Western State Med Univ, St Petersburg, Russia
[2] Far Eastern State Med Univ, Khabarovsk, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2022年 / 94卷 / 08期
关键词：
Helicobacter pylori; cancer prevention; gastroesophageal reflux disease; inflammatory bowel disease; bronchial asthma; personalized eradication; INFLAMMATORY-BOWEL-DISEASE; CLINICAL-PRACTICE; GUIDELINES; FUTURE;
D O I：
10.26442/00403660.2022.08.201787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The article is devoted to debatable aspects of Helicobacter pylori eradication therapy. The eradication cancer-preventive effects are considered. A negative comorbidity between H. pylori infection and such diseases as gastroesophageal reflux disease, inflammatory bowel disease and bronchial asthma has been described. The perspectives of populational, individualized and personalized strategies for H. pylori eradication therapy assessment are given. Recommendations for individualized H. pylori eradication strategy implementation in practical healthcare are proposed.
引用
收藏
页码：935 / 939
页数：5
相关论文
共 50 条
  • [1] Helicobacter pylori eradication: always? - contra
    Arnold, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (1-2) : 43 - 44
  • [2] Helicobacter pylori eradication therapy.: The Spanish Consensus Report
    Gisbert, JP
    Calvet, X
    Gomollón, F
    Sáinz, R
    MEDICINA CLINICA, 2000, 114 (05): : 185 - 195
  • [3] Usefulness of serology in determination of Helicobacter pylori eradication after therapy.
    Fallone, CA
    Barkun, AN
    Loo, V
    Hu, X
    GASTROENTEROLOGY, 1996, 110 (04) : A106 - A106
  • [4] Personalized medicine for eradication of Helicobacter pylori
    Furuta, Takabisa
    Sugimoto, Mitusbige
    Kodaira, Cbise
    Nishino, Masafumi
    Yamade, Mihoko
    Shirai, Naohito
    Ikuma, Mutsuhiro
    Hishida, Akira
    Ishizaki, Takashi
    PERSONALIZED MEDICINE, 2007, 4 (03) : 321 - 328
  • [5] Metronidazole resistant Helicobacter pylori after trifle agent eradication therapy.
    Takahasi, M
    Katayama, Y
    Takada, H
    Kuwayama, H
    GASTROENTEROLOGY, 2000, 118 (04) : A1312 - A1312
  • [6] Age-dependent eradication of Helicobacter pylori (Hp) with dual therapy.
    Treiber, G
    Ammon, S
    Klotz, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 417 - 417
  • [7] Helicobacter pylori reinfection and ulcer recurrence in children following eradication therapy.
    Kato, S
    Abukawa, D
    Furuyama, N
    Iinuma, K
    GASTROENTEROLOGY, 1998, 114 (04) : A170 - A170
  • [8] Personalized Helicobacter pylori eradication therapy based on clarithromycin resistance mutation
    Shin, S.
    Kim, J.
    HELICOBACTER, 2017, 22
  • [9] Personalized Approach in Eradication of Helicobacter pylori Infection
    Mestrovic, Antonio
    Perkovic, Nikola
    Tonkic, Ante
    Sundov, Zeljko
    Kumric, Marko
    Bozic, Josko
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [10] Helicobacter pylori eradication therapy
    Suzuki, Hidekazu
    Nishizawa, Toshihiro
    Hibi, Toshifumi
    FUTURE MICROBIOLOGY, 2010, 5 (04) : 639 - 648
12345